| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.014 | 0.9 |